CVM.H — CVR Medical Income Statement
0.000.00%
Last trade - 00:00
HealthcareMicro Cap
R2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 3.95 | 6.43 | 4.98 | 0.131 | 1.76 |
Operating Profit | -3.95 | -6.43 | -4.98 | -0.131 | -1.76 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -6.55 | -7.44 | -5.14 | -0.173 | -1.82 |
Net Income After Taxes | -6.55 | -7.44 | -5.14 | -0.173 | -1.82 |
Net Income Before Extraordinary Items | |||||
Net Income | -6.55 | -7.44 | -5.14 | -0.173 | -1.82 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -6.55 | -7.44 | -5.14 | -0.173 | -1.82 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.113 | -0.102 | -0.052 | -0.001 | -0.006 |
Dividends per Share |